These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34131476)

  • 1. Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women.
    Ghosh S; Kapoor D; Vijayvergiya R; Sangwan S; Wangkheimayum S; Mehta S; Dhawan V
    World J Cardiol; 2021 May; 13(5):130-143. PubMed ID: 34131476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between soluble receptor for advanced glycation end products (sRAGE) and coronary and cerebral atherosclerosis].
    Yang SH; Han XJ; Hu HY; Chen W; Yang CZ; Tian JP; Guo CX
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3062-3067. PubMed ID: 31648447
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
    Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
    Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
    Tsirebolos G; Tsoporis JN; Drosatos IA; Izhar S; Gkavogiannakis N; Sakadakis E; Triantafyllis AS; Parker TG; Rallidis LS; Rizos I
    Int J Cardiol; 2023 Apr; 376():127-133. PubMed ID: 36758863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.
    Wang X; Xu T; Mungun D; Zhou C; Zha Z; Lu M; Fen C; Guo Y
    Dis Markers; 2019; 2019():4528382. PubMed ID: 31275446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.
    Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Yoshida T; Sato A; Imaizumi T
    Diabetes Metab Res Rev; 2007 Jul; 23(5):368-71. PubMed ID: 17024691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGE-RAGE Stress and Coronary Artery Disease.
    Prasad K
    Int J Angiol; 2021 Mar; 30(1):4-14. PubMed ID: 34025091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.
    Falcone C; Bozzini S; Guasti L; D'Angelo A; Capettini AC; Paganini EM; Falcone R; Moia R; Gazzaruso C; Pelissero G
    ScientificWorldJournal; 2013; 2013():584504. PubMed ID: 24228009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
    Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
    Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
    Grauen Larsen H; Marinkovic G; Nilsson PM; Nilsson J; Engström G; Melander O; Orho-Melander M; Schiopu A
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):925-933. PubMed ID: 30917679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
    Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.
    Yan XX; Lu L; Peng WH; Wang LJ; Zhang Q; Zhang RY; Chen QJ; Shen WF
    Atherosclerosis; 2009 Aug; 205(2):544-8. PubMed ID: 19150066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis.
    Basta G; Corciu AI; Vianello A; Del Turco S; Foffa I; Navarra T; Chiappino D; Berti S; Mazzone A
    Atherosclerosis; 2010 Jun; 210(2):614-8. PubMed ID: 20074734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.